Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment (OASIS)

Center for Social Innovation, Massachusetts

Status and phase: Completed; Phase 1

Conditions: Opioid Use Disorder

Treatments: Behavioral: Overcoming and Addressing Stigma in Substance Use Disorders (OASIS)

Study type: Interventional

Funder types: Other

Identifiers

NCT06266572

1R43DA055182-01

Details and patient eligibility

About

C4 Innovations (C4) and partners at Yale University (Yale) and the West Haven VA Medical Center (WHVA) proposed to develop and test OASIS (Overcoming and Addressing Stigma in Substance Use Disorders), a web-based educational platform for primary care clinicians and individuals with Opioid Use Disorder. The major aims of the study were to:

1. Develop a prototype of OASIS for patients with Opioid Use Disorder (OUD) and primary care clinicians; conduct usability testing.
2. Pilot OASIS with a small sample of individuals with untreated OUD and their clinicians to determine feasibility, acceptability, and preliminary product effectiveness for a Phase II effectiveness trial.

After development of the prototype, the C4-Yale-WHVA team planned to test OASIS with patients (N = 30) and clinicians (N = 5) using validated measures and qualitative interviews to assess usability, satisfaction, knowledge, empowerment, and stigma.

Enrollment: 19 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

For providers:

• Clinically active and seeing patients;
• Having a device with Internet access to use the OASIS prototype
• English speaking
• Willing and able to complete data collection activities.

For patients:

• Diagnosed OUD
• Unmet substance use treatment need
• Has an upcoming primary care visit scheduled for the intervention period (1-2 months)
• English speaking
• Has access to a device with Internet access to use the OASIS prototype
• Willing and able to complete data collection activities

Exclusion criteria

Patient participants will be excluded from this study if they:

1. Currently receiving or have received medication for opioid dependence.

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

19 participants in 2 patient groups

Pre-Intervention

Experimental group

Description:

Research participants will receive access to a web-based platform designed to provide information about Opioid Use Disorder. Prior to receiving access to this application, research participants will complete online, self-reported surveys assessing stigma, empowerment, and knowledge of opioids.

Treatment:

Behavioral: Overcoming and Addressing Stigma in Substance Use Disorders (OASIS)

Post-Intervention

Experimental group

Description:

Research participants will have access to the web-based platform for 7 to 14 days prior to receiving a second, identical series of self-report surveys assessing stigma, empowerment, and knowledge of opioids. Additionally, after using the platform, research participants will complete a measure of system usability.

Treatment:

Behavioral: Overcoming and Addressing Stigma in Substance Use Disorders (OASIS)